Barinthus Biotherapeutics plc (BRNS)
NASDAQ: BRNS · Real-Time Price · USD
1.310
-0.100 (-7.04%)
Nov 5, 2024, 11:13 AM EST - Market open
Barinthus Biotherapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
Nov '24 Nov 5, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Market Capitalization | 52 | 142 | 88 | 388 | - | - |
Market Cap Growth | -30.86% | 62.36% | -77.38% | - | - | - |
Enterprise Value | -48 | -5 | -104 | 162 | - | - |
Last Close Price | 1.45 | 3.69 | 2.35 | 11.11 | - | - |
PE Ratio | - | -1.93 | 16.79 | -5.66 | - | - |
PS Ratio | - | 177.44 | 1.96 | 1445.93 | - | - |
PB Ratio | 0.36 | 0.76 | 0.36 | 1.53 | - | - |
P/FCF Ratio | -0.99 | -2.53 | -4.26 | -11.49 | - | - |
P/OCF Ratio | -1.00 | -2.79 | -6.07 | -11.89 | - | - |
EV/Sales Ratio | - | -6.35 | -2.32 | 605.57 | - | - |
EV/EBITDA Ratio | 0.95 | 0.07 | 59.33 | -3.98 | - | - |
EV/EBIT Ratio | 0.91 | 0.06 | 36.15 | -3.94 | - | - |
EV/FCF Ratio | 1.13 | 0.09 | 5.05 | -4.81 | - | - |
Debt / Equity Ratio | 0.08 | 0.07 | 0.04 | 0.03 | -14.73 | 0.15 |
Debt / FCF Ratio | -0.23 | -0.23 | -0.43 | -0.21 | -4.10 | -0.09 |
Asset Turnover | - | 0.00 | 0.16 | 0.00 | 0.14 | - |
Quick Ratio | 7.92 | 11.91 | 16.87 | 19.81 | 6.12 | 2.67 |
Current Ratio | 8.46 | 12.45 | 17.40 | 20.32 | 6.27 | 2.83 |
Return on Equity (ROE) | -34.13% | -34.15% | 2.15% | -40.99% | -420.05% | - |
Return on Assets (ROA) | -19.70% | -20.73% | -0.65% | -15.55% | -30.07% | - |
Return on Capital (ROIC) | -21.37% | -22.24% | -0.70% | -17.00% | -36.98% | - |
Earnings Yield | -111.87% | -51.54% | 6.09% | -13.13% | - | - |
FCF Yield | -96.47% | -39.59% | -23.47% | -8.70% | - | - |
Buyback Yield / Dilution | -2.59% | -0.57% | -47.40% | -227.59% | -33580.72% | - |
Total Shareholder Return | -2.59% | -0.57% | -47.40% | -227.59% | -33580.72% | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.